elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31019795-4E9EEEA8-BF8F-4C40-ABBC-C3BFE86CBB77
Q31019795-4E9EEEA8-BF8F-4C40-ABBC-C3BFE86CBB77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31019795-4E9EEEA8-BF8F-4C40-ABBC-C3BFE86CBB77
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.
P2860
Q31019795-4E9EEEA8-BF8F-4C40-ABBC-C3BFE86CBB77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31019795-4E9EEEA8-BF8F-4C40-ABBC-C3BFE86CBB77
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a74668ab9b02c39eee6dd8eb347dcd5e2526fd4
P2860
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?